CAS: 137132-70-8 - 8,11-dihydroxy-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)-1,2,3,4,7,12-hexahydronaphtho(2,3-f)quinoxaline-7,12-dione
Fórmula:C22H26N4O6
InChI:InChI=1/C22H26N4O6/c27-9-6-23-3-4-24-12-11-13-20(25-5-7-26(13)8-10-28)19-16(12)21(31)17-14(29)1-2-15(30)18(17)22(19)32/h1-2,11,23-25,27-30H,3-10H2
- Sinónimos:
- Dhhnqd
- Naphtho(2,3-f)quinoxaline-7,12-dione, 8,11-dihydroxy-1,2,3,4-tetrahydro-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)-
- 8,11-Dihydroxy-4-(2-Hydroxyethyl)-6-({2-[(2-Hydroxyethyl)Amino]Ethyl}Amino)-1,2,3,4-Tetrahydronaphtho[2,3-F]Quinoxaline-7,12-Dione
Mitoxantrone EP Impurity D HCl
Fórmula:
C22H26N4O6·HCl
Forma y color:
Dark Blue Solid
Peso molecular:
442.48 36.46
Ref: 4Z-M-088004
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 3 de Diciembre de 2024
Mitoxantrone (2-Hydroxyethyl)piperazine Impurity(Mitoxantrone Impurity D)
Producto controladoCAS:137132-70-8
Applications A metabolite of the anticancer agent Mitoxantrone (M373425) References Feafanov, A. et al.: Anticcancer …
Fórmula:
C22H26N4O6
Forma y color:
Neat
Peso molecular:
442.46
Ref: TR-M373435
25mg | 243,00 € | ||
50mg | 325,00 € | ||
100mg | 589,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Mitoxantrone (2-hydroxyethyl)piperazine impurity
CAS:137132-70-8
Mitoxantrone is an anticancer drug that is used to treat various types of cancer. Mitoxantrone …
Fórmula:
C22H26N4O6
Pureza:
Min. 95%
Forma y color:
Brown Powder
Peso molecular:
442.47 g/mol
Ref: 3D-IM26023
25mg | 324,00 € | ||
50mg | 494,00 € | ||
100mg | 855,00 € | ||
250mg | 1.468,00 € | ||
500mg | 2.667,00 € |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025